Allspring Global Investments Holdings LLC Boosts Stake in Chemed Corporation $CHE

Allspring Global Investments Holdings LLC grew its stake in Chemed Corporation (NYSE:CHE) by 18.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 99,408 shares of the company’s stock after acquiring an additional 15,704 shares during the quarter. Allspring Global Investments Holdings LLC owned about 0.70% of Chemed worth $42,128,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in the stock. Smartleaf Asset Management LLC grew its position in shares of Chemed by 71.4% in the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after buying an additional 25 shares during the last quarter. First Horizon Corp purchased a new stake in Chemed during the third quarter valued at approximately $31,000. Pilgrim Partners Asia Pte Ltd acquired a new stake in Chemed in the third quarter valued at approximately $45,000. HM Payson & Co. grew its holdings in Chemed by 35.5% in the third quarter. HM Payson & Co. now owns 103 shares of the company’s stock worth $46,000 after purchasing an additional 27 shares during the last quarter. Finally, Geneos Wealth Management Inc. grew its holdings in Chemed by 330.4% in the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after purchasing an additional 76 shares during the last quarter. 95.85% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the company. Weiss Ratings reissued a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Oppenheimer reduced their target price on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday, February 27th. Zacks Research cut Chemed from a “hold” rating to a “strong sell” rating in a research note on Wednesday, March 4th. Royal Bank Of Canada reissued a “sector perform” rating and issued a $422.00 price target (down from $572.00) on shares of Chemed in a report on Friday, February 27th. Finally, Jefferies Financial Group lowered Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, January 22nd. Two investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $498.00.

Chemed Price Performance

Shares of CHE stock opened at $380.46 on Friday. The business has a fifty day moving average of $422.33 and a 200 day moving average of $433.38. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $623.60. The firm has a market capitalization of $5.24 billion, a price-to-earnings ratio of 20.71, a price-to-earnings-growth ratio of 1.50 and a beta of 0.49.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share for the quarter, missing the consensus estimate of $7.02 by ($0.60). Chemed had a net margin of 10.48% and a return on equity of 25.66%. The firm had revenue of $639.34 million for the quarter, compared to analysts’ expectations of $659.09 million. During the same quarter in the previous year, the firm posted $6.83 EPS. The firm’s revenue for the quarter was down .1% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. As a group, equities research analysts expect that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, February 23rd were issued a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend was Monday, February 23rd. Chemed’s dividend payout ratio is 13.06%.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $403.18, for a total transaction of $806,360.00. Following the completion of the transaction, the chief executive officer owned 93,719 shares of the company’s stock, valued at $37,785,626.42. This trade represents a 2.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 3.29% of the stock is owned by company insiders.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.